Loading cancer entity…
Loading cancer entity…
Population statistics describe groups defined by geography, period and sex. They do not predict any individual outcome. Values labelled "estimated" or "projected" are model outputs from the source, not registry counts.
United States
Unit: per 100,000 · standard population: 2000 U.S. standard population (19 age groups)
| Year | Sex | Age group | Value (per 100,000) | 95% CI | Type | Site definition | Source |
|---|---|---|---|---|---|---|---|
| 2023 | All | All ages | 7.4 | 7.3–7.4 | observed | USCS "Myeloma" (ICD-10 C90.0, C90.2; ICD-O-3 histology 9731-9732, 9734) | cdc-uscs |
| 2023 | Female | All ages | 6 | 5.9–6.1 | observed | USCS "Myeloma" (ICD-10 C90.0, C90.2; ICD-O-3 histology 9731-9732, 9734) | cdc-uscs |
| 2023 | Male | All ages | 9 | 8.9–9.2 | observed | USCS "Myeloma" (ICD-10 C90.0, C90.2; ICD-O-3 histology 9731-9732, 9734) | cdc-uscs |
| 2022 | All | All ages | 7.2 | 7.1–7.3 | observed | USCS "Myeloma" (ICD-10 C90.0, C90.2; ICD-O-3 histology 9731-9732, 9734) | cdc-uscs |
Showing the 12 most recent rows of 75; every year is plotted above and available via the API.
Data updated 22 days agoSource updated USCS 1999-2023 ASCII package, Nov 2025 submission (last-modified Thu, 04 Jun 2026 20:40:00 GMT; sha256 291765c997e5)
United States
Unit: per 100,000 · standard population: 2000 U.S. standard population (19 age groups)
United States
Unit: count
United States
Unit: count
United States
Unit: per 100,000
Data updated 21 days agoSource updated unknown369 observations
| 2022 | Female | All ages | 5.9 | 5.8–6 | observed | USCS "Myeloma" (ICD-10 C90.0, C90.2; ICD-O-3 histology 9731-9732, 9734) | cdc-uscs |
| 2022 | Male | All ages | 8.8 | 8.7–8.9 | observed | USCS "Myeloma" (ICD-10 C90.0, C90.2; ICD-O-3 histology 9731-9732, 9734) | cdc-uscs |
| 2021 | All | All ages | 7.4 | 7.3–7.5 | observed | USCS "Myeloma" (ICD-10 C90.0, C90.2; ICD-O-3 histology 9731-9732, 9734) | cdc-uscs |
| 2021 | Female | All ages | 6.1 | 6–6.2 | observed | USCS "Myeloma" (ICD-10 C90.0, C90.2; ICD-O-3 histology 9731-9732, 9734) | cdc-uscs |
| 2021 | Male | All ages | 9 | 8.9–9.2 | observed | USCS "Myeloma" (ICD-10 C90.0, C90.2; ICD-O-3 histology 9731-9732, 9734) | cdc-uscs |
| 2020 | All | All ages | 7 | 6.9–7.1 | observed | USCS "Myeloma" (ICD-10 C90.0, C90.2; ICD-O-3 histology 9731-9732, 9734) | cdc-uscs |
| 2020 | Female | All ages | 5.8 | 5.7–5.9 | observed | USCS "Myeloma" (ICD-10 C90.0, C90.2; ICD-O-3 histology 9731-9732, 9734) | cdc-uscs |
| 2020 | Male | All ages | 8.5 | 8.3–8.6 | observed | USCS "Myeloma" (ICD-10 C90.0, C90.2; ICD-O-3 histology 9731-9732, 9734) | cdc-uscs |
| Year | Sex | Age group | Value (per 100,000) | 95% CI | Type | Site definition | Source |
|---|---|---|---|---|---|---|---|
| 2024 | All | All ages | 2.6 | 2.5–2.6 | observed | USCS "Myeloma" (ICD-10 C90.0, C90.2; ICD-O-3 histology 9731-9732, 9734) | cdc-uscs |
| 2024 | All | All ages | 2.7 | 2.6–2.7 | observed | C88, C90 | cdc-wonder |
| 2024 | Female | All ages | 2.1 | 2–2.1 | observed | C88, C90 | cdc-wonder |
| 2024 | Female | All ages | 2 | 1.9–2.1 | observed | USCS "Myeloma" (ICD-10 C90.0, C90.2; ICD-O-3 histology 9731-9732, 9734) | cdc-uscs |
| 2024 | Male | All ages | 3.3 | 3.2–3.4 | observed | USCS "Myeloma" (ICD-10 C90.0, C90.2; ICD-O-3 histology 9731-9732, 9734) | cdc-uscs |
| 2024 | Male | All ages | 3.4 | 3.3–3.5 | observed | C88, C90 | cdc-wonder |
| 2023 | All | All ages | 2.8 | 2.8–2.9 | observed | C88, C90 | cdc-wonder |
| 2023 | All | All ages | 2.7 | 2.6–2.7 | observed | USCS "Myeloma" (ICD-10 C90.0, C90.2; ICD-O-3 histology 9731-9732, 9734) | cdc-uscs |
| 2023 | Female | All ages | 2.3 | 2.2–2.3 | observed | C88, C90 | cdc-wonder |
| 2023 | Female | All ages | 2.2 | 2.1–2.2 | observed | USCS "Myeloma" (ICD-10 C90.0, C90.2; ICD-O-3 histology 9731-9732, 9734) | cdc-uscs |
| 2023 | Male | All ages | 3.3 | 3.2–3.4 | observed | USCS "Myeloma" (ICD-10 C90.0, C90.2; ICD-O-3 histology 9731-9732, 9734) | cdc-uscs |
| 2023 | Male | All ages | 3.5 | 3.4–3.6 | observed | C88, C90 | cdc-wonder |
Showing the 12 most recent rows of 99; every year is plotted above and available via the API.
Data updated 21 days agoSource updated USCS 1999-2023 ASCII package, Nov 2025 submission (last-modified Thu, 04 Jun 2026 20:40:00 GMT; sha256 291765c997e5)
| Year | Sex | Age group | Value (count) | 95% CI | Type | Site definition | Source |
|---|---|---|---|---|---|---|---|
| 2023 | All | All ages | 32,131 | — | observed | USCS "Myeloma" (ICD-10 C90.0, C90.2; ICD-O-3 histology 9731-9732, 9734) | cdc-uscs |
| 2023 | Female | All ages | 13,969 | — | observed | USCS "Myeloma" (ICD-10 C90.0, C90.2; ICD-O-3 histology 9731-9732, 9734) | cdc-uscs |
| 2023 | Male | All ages | 18,162 | — | observed | USCS "Myeloma" (ICD-10 C90.0, C90.2; ICD-O-3 histology 9731-9732, 9734) | cdc-uscs |
| 2022 | All | All ages | 30,915 | — | observed | USCS "Myeloma" (ICD-10 C90.0, C90.2; ICD-O-3 histology 9731-9732, 9734) | cdc-uscs |
| 2022 | Female | All ages | 13,584 | — | observed | USCS "Myeloma" (ICD-10 C90.0, C90.2; ICD-O-3 histology 9731-9732, 9734) | cdc-uscs |
| 2022 | Male | All ages | 17,331 | — | observed | USCS "Myeloma" (ICD-10 C90.0, C90.2; ICD-O-3 histology 9731-9732, 9734) | cdc-uscs |
| 2021 | All | All ages | 30,979 | — | observed | USCS "Myeloma" (ICD-10 C90.0, C90.2; ICD-O-3 histology 9731-9732, 9734) | cdc-uscs |
| 2021 | Female | All ages | 13,629 | — | observed | USCS "Myeloma" (ICD-10 C90.0, C90.2; ICD-O-3 histology 9731-9732, 9734) | cdc-uscs |
| 2021 | Male | All ages | 17,350 | — | observed | USCS "Myeloma" (ICD-10 C90.0, C90.2; ICD-O-3 histology 9731-9732, 9734) | cdc-uscs |
| 2020 | All | All ages | 28,995 | — | observed | USCS "Myeloma" (ICD-10 C90.0, C90.2; ICD-O-3 histology 9731-9732, 9734) | cdc-uscs |
| 2020 | Female | All ages | 12,910 | — | observed | USCS "Myeloma" (ICD-10 C90.0, C90.2; ICD-O-3 histology 9731-9732, 9734) | cdc-uscs |
| 2020 | Male | All ages | 16,085 | — | observed | USCS "Myeloma" (ICD-10 C90.0, C90.2; ICD-O-3 histology 9731-9732, 9734) | cdc-uscs |
Showing the 12 most recent rows of 75; every year is plotted above and available via the API.
Data updated 22 days agoSource updated USCS 1999-2023 ASCII package, Nov 2025 submission (last-modified Thu, 04 Jun 2026 20:40:00 GMT; sha256 291765c997e5)
| Year | Sex | Age group | Value (count) | 95% CI | Type | Site definition | Source |
|---|---|---|---|---|---|---|---|
| 2024 | All | All ages | 11,967 | — | observed | C88, C90 | cdc-wonder |
| 2024 | All | All ages | 11,404 | — | observed | USCS "Myeloma" (ICD-10 C90.0, C90.2; ICD-O-3 histology 9731-9732, 9734) | cdc-uscs |
| 2024 | Female | All ages | 5,217 | — | observed | C88, C90 | cdc-wonder |
| 2024 | Female | All ages | 4,981 | — | observed | USCS "Myeloma" (ICD-10 C90.0, C90.2; ICD-O-3 histology 9731-9732, 9734) | cdc-uscs |
| 2024 | Male | All ages | 6,423 | — | observed | USCS "Myeloma" (ICD-10 C90.0, C90.2; ICD-O-3 histology 9731-9732, 9734) | cdc-uscs |
| 2024 | Male | All ages | 6,750 | — | observed | C88, C90 | cdc-wonder |
| 2023 | All | All ages | 12,151 | — | observed | C88, C90 | cdc-wonder |
| 2023 | All | All ages | 11,577 | — | observed | USCS "Myeloma" (ICD-10 C90.0, C90.2; ICD-O-3 histology 9731-9732, 9734) | cdc-uscs |
| 2023 | Female | All ages | 5,518 | — | observed | C88, C90 | cdc-wonder |
| 2023 | Female | All ages | 5,283 | — | observed | USCS "Myeloma" (ICD-10 C90.0, C90.2; ICD-O-3 histology 9731-9732, 9734) | cdc-uscs |
| 2023 | Male | All ages | 6,633 | — | observed | C88, C90 | cdc-wonder |
| 2023 | Male | All ages | 6,294 | — | observed | USCS "Myeloma" (ICD-10 C90.0, C90.2; ICD-O-3 histology 9731-9732, 9734) | cdc-uscs |
Showing the 12 most recent rows of 99; every year is plotted above and available via the API.
Data updated 21 days agoSource updated USCS 1999-2023 ASCII package, Nov 2025 submission (last-modified Thu, 04 Jun 2026 20:40:00 GMT; sha256 291765c997e5)
| Year | Sex | Age group | Value (per 100,000) | 95% CI | Type | Site definition | Source |
|---|---|---|---|---|---|---|---|
| 2024 | All | All ages | 3.5 | 3.5–3.6 | observed | C88, C90 | cdc-wonder |
| 2024 | Female | All ages | 3 | 3–3.1 | observed | C88, C90 | cdc-wonder |
| 2024 | Male | All ages | 4 | 3.9–4.1 | observed | C88, C90 | cdc-wonder |
| 2023 | All | All ages | 3.6 | 3.6–3.7 | observed | C88, C90 | cdc-wonder |
| 2023 | Female | All ages | 3.3 | 3.2–3.3 | observed | C88, C90 | cdc-wonder |
| 2023 | Male | All ages | 4 | 3.9–4.1 | observed | C88, C90 | cdc-wonder |
| 2022 | All | All ages | 3.8 | 3.7–3.9 | observed | C88, C90 | cdc-wonder |
| 2022 | Female | All ages | 3.3 | 3.3–3.4 | observed | C88, C90 | cdc-wonder |
| 2022 | Male | All ages | 4.2 | 4.1–4.3 | observed | C88, C90 | cdc-wonder |
| 2021 | All | All ages | 3.9 | 3.8–4 | observed | C88, C90 | cdc-wonder |
| 2021 | Female | All ages | 3.4 | 3.3–3.5 | observed | C88, C90 | cdc-wonder |
| 2021 | Male | All ages | 4.4 | 4.3–4.5 | observed | C88, C90 | cdc-wonder |
Showing the 12 most recent rows of 21; every year is plotted above and available via the API.
Data updated 21 days agoSource updated D158 vintage 2024